coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Walton Practices Confederation PCN, Elmbridge · Health Inequalities Profile

    PCN U10870 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    21,036

    Registered population

    61.5% aged 18–64

    17.1%

    Aged 65+

    ICB 18.8% · England 17.9%

    14.1%

    Ethnic minority (non-White)

    6.4% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    2,727

    Hypertension register

    +1.22% in 3 yrs · England +5.60%

    197

    SMI register

    17.4% of Elmbridge's

    231

    COPD register

    Reviews +13.36% in 3 yrs

    Forecast to 2030

    2,863

    Hypertension patients, 2030

    +136 on today

    62.4%

    QRISK ≥20% on statins, 2030

    +1.23pp over 3 yrs

    3.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -4.2%
    Cardiovascular and diabetes control slipped over three years.

    Over 2023 to 2025, non-frail diabetes HbA1c control changed -4.2% (England +4.4%), under-80 BP control -3.5% (England +3.2%), with QRISK >= 20% lipid therapy.

    10.2 pp
    Age-five booster drop-off and wide practice variation.

    In Q1 2025/26, age-5 MMR coverage dropped 10.2 pp from dose 1 (92.6%) to dose 2 (82.4%), 4-in-1 reached 76.5%, and QOF vaccination spanned.

    84.4%
    Strong COPD review and psychosis recording gains.

    COPD annual reviews reached 84.4% (+13.4% over 2023 to 2025 vs England +2.8%), and psychosis alcohol recording rose +21.3 pp to 88.7% (England 81.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A list of 21,036 patients has a younger profile alongside 215 care beds

    Walton Practices Confederation PCN registers 21,036 patients. Children aged 0–17 comprise 21.5% (4,515 patients), compared with 21.7% in Elmbridge, 20.4% in NHS Surrey Heartlands ICB and 19.6% in England. Those aged 65+ represent 17.1% (3,588 patients), below Elmbridge (17.9%), the ICB (18.8%) and England (17.9%), while 61.5% (12,933) are aged 18–64. Ethnicity data reflects Census usual residents in associated areas rather than registered patients: 85.9% are White (Elmbridge 86.1%, ICB 85.3%, England 81.1%) and 14.1% belong to ethnic minorities, including 6.4% Asian residents (Elmbridge 6.5%, ICB 7.7%, England 9.6%).

    Age profile

    0–1721.5%
    18–6461.5%
    65+17.1%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White85.9%
    Asian6.4%
    Mixed4.3%
    Other1.9%
    Black1.6%

    Older people · falls rows are Elmbridge local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Elmbridge LA)2,0032,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)76.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.7%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Elmbridge LA)8959819552024/25
    Falls deaths, all ages, per 100,000 (Elmbridge LA)10.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.7 with 0.0% of registered patients in Core20 areas

    Walton Practices Confederation PCN records 0.0% of its 21,036 registered patients in Core20, matching Elmbridge (0.0%) and below NHS Surrey Heartlands Integrated Care Board (0.8%) and England (21.0%). Average IMD decile is 7.7 (Elmbridge 8.6, ICB 7.9, England 5.5). Core20 share is 0.0% across all four practices (0 estimated patients); captured practice IMD deciles are 7.7 at The Yellow Practice and 8.1 at The Red Practice Walton. With zero Core20 area deprivation, local inequality work may achieve greater reach by targeting vulnerable clinical and inclusion cohorts.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Red Walton0.0% · 0 patients
    Yellow0.0% · 0 patients
    White0.0% · 0 patients
    Ashley Medical0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    197

    SMI register

    0.89% recorded prevalence

    88

    Learning disability register

    0.40% recorded prevalence

    5

    Care homes, 215 beds

    In the PCN catchment

    7.4%

    Provide unpaid care

    Elmbridge, Census 2021

    Recorded inclusion registers include 197 patients with severe mental illness (0.9% vs Elmbridge 0.7%, ICB 0.8%, England 1.0%) and 88 with learning disabilities (0.4% vs Elmbridge 0.3%, ICB 0.5%, England 0.6%). Catchment care capacity spans 215 beds across five homes.

    Severe mental illness: physical health checks

    Severe mental illness blood pressure check completion reached 78.2% across 197 patients, trailing England (83.4%) despite a +14.5 pp rise over 2023 to 2025 (England +4.4 pp). Ashley Medical Practice recorded 53.3%.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    2,727

    Hypertension register

    +1.22%

    Register growth, 3 yrs

    Elmbridge +5.83% · England +5.60%

    −2.60pp

    BP control, under 80

    ≤140/90 · −1.97pp aged 80+

    +136

    More patients by 2030

    Forecast 2,863 (12.63%)

    Hypertension case-finding and control

    Hypertension register prevalence is 12.3% (2,727 patients), below Elmbridge (12.6%), NHS Surrey Heartlands Integrated Care Board (14.3%) and England (15.2%). Blood pressure treated to target is 74.5% (England 70.3%) and under-80s control is 72.3% (England 67.8%). However, over 2023 to 2025, patients treated to target fell 2.9% (England +3.6%) and under-80s control fell 3.5% (England +3.2%).

    Lipids and statins

    Lipid-lowering therapy uptake for QRISK ≥ 20% patients is 59.9%, trailing England (63.6%) while exceeding Elmbridge (55.9%). Over 2023 to 2025, uptake rose +2.1%, lagging England (+6.2%) and NHS Surrey Heartlands Integrated Care Board (+6.1%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202625,706£2.10£2.24£1.86£53,983
    Cardiovascular (all), 202538,953£4.83£4.74£3.33£188,143

    For lipid-regulating drugs in 2026, the PCN prescribed 25,706 items with an annual spend of £53,983 at £2.10 per item, compared to England (£1.86), Elmbridge (£2.25) and NHS Surrey Heartlands Integrated Care Board (£2.24). Across these items, the PCN spends £6,169 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +1.98%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +4.57%

    Asthma prevalence, PCN 3-yr % change

    COPD annual reviews reached 84.4% across 231 patients, exceeding England (76.4%) following a +13.4% change over 2023 to 2025 (England +2.8%). Asthma annual reviews reached 69.1% (England 65.7%, Elmbridge 61.6%), leaving about 280 patients (277) without a recorded review on the 896-patient register. For patients aged 5–19, asthma management prescribing was 1,156 rate per 1,000, below England (1,488 rate) and above Elmbridge (732 rate).

    Cancer register and children's immunisation

    In Q1 2025/26, 24-month 6-in-1 coverage was 96.2%, exceeding the 95.0% target. At age 5, coverage was 82.4% for MMR dose 2 (below the 95.0% target by 12.6 pp) and 76.5% for the 4-in-1 booster (below the 95.0% target by 18.5 pp), with a 10.2 pp drop between MMR doses. Cancer prevalence is 3.3% (727 patients; England 3.8%).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months89.4%

    England 91.0%

    6-in-1 complete primary course at 24 months96.2%

    England 92.2%

    MMR dose 1 at 24 months92.3%

    England 88.3%

    MMR dose 2 at age 582.4%

    England 82.8%

    4-in-1 pre-school booster at age 576.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, across NHS Surrey Heartlands ICB (wider system data, not PCN level), 61.4% of staged cancers (2,955 of 4,810) were diagnosed at stage 1 or 2, above England (55.3%) but 13.6 pp below the 75.0% national ambition, with staging known for 67.7% (4,810 of 7,106). Reaching 75.0% requires about 650 additional early diagnoses across the ICB. At PCN level, cervical screening coverage in women aged 25–49 is 65.7% (England 66.8%, ICB 69.3%), with Ashley Medical Practice at 56.3%. PCN breast screening coverage is 68.5% (ICB 71.2%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), for wider trust performance (not PCN performance), Ashford and St Peter's Hospitals NHS Foundation Trust achieved 76.4% for the 62-day referral to treatment standard (standard 85.0%), exceeding NHS Surrey and Sussex Integrated Care Board (71.5%) and England (71.2%). Epsom and St Helier University Hospitals NHS Trust achieved 86.8% and Kingston and Richmond NHS Foundation Trust 75.3%. Ashford and St Peter's met the 28-day faster diagnosis standard at 85.5% (standard 75.0%). Trust diagnostic 6+ week waits were 57.9% for flexi sigmoidoscopy, 56.7% for gastroscopy and 49.6% for colonoscopy.

    Pathways within standard (%)Ashford and St Peter'sKingston and RichmondEpsom and St HelierSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5380.0789.7079.2979.32
    31-day treatment (96%)94.2198.7799.1690.4592.50
    62-day referral to treatment (85%)76.3875.3286.8271.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sKingston and RichmondEpsom and St HelierEngland
    MRI0.090.190.3121.40
    CT9.270.001.069.92
    Echocardiography0.974.8925.4928.48
    Colonoscopy49.6170.1733.0130.83
    Gastroscopy56.7479.1830.9029.02
    All 15 DM01 tests23.1231.566.8323.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In Jun 2026 (provisional), at local authority level (not PCN performance), adults aged 65 and over accounted for 69.6% of all community service contacts among Elmbridge borough residents (76,215 of 109,530 contacts). This borough-level concentration highlights that community care contacts are heavily concentrated among older residents.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Vaccination achievement spans 51.3 percentage points and phone access spans 33.0 percentage points

    In 2025/26, QOF vaccination achievement spanned 51.3 percentage points, from 47.3% at Ashley Medical Practice to 98.6% at The Red Practice Walton. Clinical achievement was 100.0% at Ashley Medical Practice alongside a 21.4% personalised care adjustment rate; local administrative and recall audits would be required to test variation across practices.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Red Walton1090.041.6%71.5%82.4%
    Yellow1010.047.4%51.2%75.3%
    The White Practice890.074.6%69.3%73.1%
    Ashley Medical870.049.9%63.8%58.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNElmbridgeAssetPCNElmbridge
    Care homes (catchment)5 (215 beds)n/aSchools (catchment)27n/a
    Children's centres28Places of worship1859
    Libraries26Homelessness support (VCS)0no data
    Day centres (VCS)n/a2Carers support groups (VCS)n/a1
    Primary schools (LA maintained)215Primary academies311
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Targeted SMI blood pressure recall

    SMI register with a BP check in the last 12 months is 78.2% (current basis, with 197 patients on the SMI register, despite a +14.5 pp 3-year change from 2023 to 2025), compared with Elmbridge (81.7 percent, -3.5 percentage points), NHS Surrey Heartlands Integrated Care Board (83.5 percent, -5.3 percentage. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 2

    Asthma annual review recall

    Asthma review completion is 69.1% on the 896-patient register (England 65.7%, Elmbridge 61.6%), leaving 277 patients (about 280) without a recorded review. For discussion: practices could run a single-template recall for unreviewed asthma patients, pairing inhaler checks with flexible review slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Age-five pre-school booster recall

    In Q1 2025/26 (cohort 68), age 5 coverage was 82.4% for MMR2 (below 95.0% by 12.6 pp) and 76.5% for 4-in-1 (below by 18.5 pp), dropping 10.2 pp from MMR1 (92.6%). Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Inclusion health cohort audit (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Targeted SMI blood pressure recall (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 2 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Age-five pre-school booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15